wydrukuj poleć znajomym zamów materiały
Od ilu lat pracuje Pani/Pan na różnych stanowiskach menedżerskich:

powyżej 20 lat
powyżej 15 lat
powyżej 10 lat
powyżej 5 lat
poniżej 5 lat
jeszcze nie byłam/-em menedżerem
nie chcę być menedżerem

Subskrypcja najnowszych ofert pracy

Nasi partnerzy:


Sanofi-aventis appoints New Senior Managers in Emerging Markets 2011.01.08

Paris, France - January 7, 2011 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the appointment of new Senior Managers in Emerging Markets, effective February 1, 2011.

Pharmaceuticals manufacturing site in Beijing, China.
Photo: sanofi-aventis

Paris, France - January 7, 2011

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the appointment of new Senior Managers in Emerging Markets, effective February 1, 2011.

Hanspeter Spek - Member of the Executive Committee and the Management Committee - President, Global Operations, sanofi-aventis.
Photo: sanofi-aventis
“These appointments reflect the dynamics of our businesses and the opportunities we will continue to seize in those regions in order to reinforce sanofi-aventis’ leadership position in the emerging markets”, declared Hanspeter Spek, President, Global Operations, sanofi-aventis.
“The depth of talent, knowledge and experience of the managers we appointed today make them ideally suited to achieve our ambition”.

Pharmaceuticals manufacturing site in Fawdon, Great Britain.
Photo: sanofi-aventis

Patrick Aghanian is appointed Head of the Eurasia Region.

He is currently Head of Russia, and will also take responsibility for Ukraine, Belarus and the Central Asia platform based in Kazakhstan.
He worked in various positions at SC Johnson and Son in purchasing, sales and marketing before joining GlaxoSmithKline in 1995 as General Manager Ukraine, then Russia and CIS.
He then joined Novartis as General Manager Russia, in 2003 and Sandoz Russia in 2007, prior to joining sanofi-aventis as General Manager Russia in 2008.

Thomas Kelly is appointed Head of the Asia Region.

He is currently Head of Greater China and will also take responsibility for the South East Asian region including Thailand, Singapore, Malaysia, Indonesia, Vietnam and the Philippines.
He began his career in marketing at Johnson & Johnson in China and joined Novo Nordisk Biotechnology Co, Ltd as Sales and Marketing Director in 1995 and was appointed General Manager in 1998.
In 1999, he joined Shanghai Schering-Plough in China as General Manager, and sanofi-aventis as General Manager China in 2006.

Pharmaceuticals manufacturing site in Thu Duc, Vietnam.
Photo: sanofi-aventis

Heraldo Marchezini is appointed Head of the Latin America Region.

He is currently Head of Brazil.
He began his career with Rhodia and Aventis in Brazil working in various positions in sales and marketing, including Product Manager in consumer healthcare and Hospital and Oncology Director.
He then served as Poland, Baltic Region General Manager for Aventis and was appointed General Manager for Brazil in 2004.

Pharmaceuticals manufacturing site in Sao-Paulo, Brazil.
Photo: sanofi-aventis

Jeremy Moulding is appointed Head of the Japan & Pacific Region.

He is currently Head of Japan, Australia and New Zealand and will also take responsibility for Korea.
After having served in Astra-Zeneca for 5 years, Jeremy began his career within the Group in 1998 and has been in marketing and commercial roles in the United Kingdom, and later in general management roles in South Africa, Korea and Australia.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.

is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi-aventis Group head office.
Photo: sanofi-aventis
Focused on patients’ needs, sanofi-aventis offers a range of essential healthcare assets, including a broad-based product portfolio and a presence worldwide.

At a glance:

• 2009 sales: €29.3 billion growth of 6.3%

• A broad portfolio of pharmaceutical products: prescription medicines, generics, consumer health care and animal health

• World leader in human vaccines

• A broad and balanced presence on both traditional and emerging markets

• More than 105,000 employees in over 110 countries

Group strategy

Our ambition is to become a diversified global healthcare leader.
Our strategy is built around three priorities to reach its goals and ensure sustainable growth:

• Innovation in Research and Development

• Adaptation of Group structures

• External growth opportunities

For more information, visit Sanofi-aventis on the Internet:


Media Relations:

Tel. : (+) 33 1 53 77 44 50
E-mail : MR@sanofi-aventis.com

Investor Relations:

Tel. : (+) 33 1 53 77 45 45
E-mail : IR@sanofi-aventis.com

SOURCE: Sanofi-aventis


ASTROMAN magazine

wydrukuj ten artykuł
  strona: 1 z 1
polecamy artykuły
IBM and NVIDIA Collaborate to Expand Open Source Machine Learning Tools for Data Scientists
Blackbaud and Microsoft expand partnership with an integrated cloud initiative for nonprofits
Airbus and Atos awarded major cyber security contract to protect key the European Union institutions
Airbus Board of Directors Selects Guillaume Faury Future Chief Executive Officer
Hong Kong Small and Medium Enterprises Expand Global Footprint
Volvo FH milestone - millionth truck delivered at IAA in Hannover
Volvo Trucks presents future transport solution with autonomous electric vehicles
Prof. Andrzej K. Koźmiński: Trzy bariery dalszego rozwoju Polski
Volvo Trucks to introduce all-electric trucks in North America
Hong Kong: Smart Solutions for Fast-paced City
Ola Källenius to become Chairman of the Board of Management of Daimler AG in 2019
Lockheed Martin Selects Harris Corporation to Deliver F-35's Next Generation Computer Processor
Raytheon awarded production contract for Poland's Patriot
FTSE Russell promoted Poland from emerging market to developed market
Poland promoted to Developed Market status by FTSE Russell
strona główna  |  oferty pracy  |  executive search  |  ochrona prywatności  |  warunki używania  |  kontakt     RSS feed subskrypcja RSS
Copyright ASTROMAN © 1995-2018. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: TAU CETI.